Coherus Oncology, Inc. (CHRS) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Coherus Oncology, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:06.316 Good day and thank you for standing by. Welcome to the Q4 and full year 2025 00:00:06.316 -- 00:00:10.480 Coherus Oncology Inc. Earnings Conference Call. 00:00:10.480 -- 00:00:14.884 At this time, all participants are in a listen-only mode. 00:00:14.884 -- 00:00:19.007 After the speaker's presentation, there will be a question and answer session. 00:00:19.007 -- 00:00:24.091 To ask a question during the session, you will need to press star 1, 1 00:00:24.091 -- 00:00:29.176 on your telephone. You will then hear an automated message advising your hand is 00:00:29.176 -- 00:00:35.287 raised. To withdraw your question, please press star 1, 1 again. 00:00:35.287 -- 00:00:38.511 Please be advised that today's conference is being recorded. 00:00:38.511 -- 00:00:43.378 I would now like to hand the conference over to your speaker today, Carrie Graham. 00:00:43.378 -- 00:00:45.681 Please go ahead. 00:00:45.681 -- 00:00:50.528 Thank you, Heidi. Good afternoon, and welcome to Hill-Harris Oncology's fourth quarter 00:00:50.528 -- 00:00:54.113 and 2025 year-end earnings conference call. 00:00:54.113 -- 00:00:58.579 Joining me today to discuss our results are Denny Lansfair, Chief Executive Officer of 00:00:58.579 -- 00:01:04.096 Hill-Harris, Dr. Teresa Lavallee, Chief Scientific and Development Officer, Dr. 00:01:04.096 -- 00:01:09.502 Rosh Gaius, Chief Medical Officer, Samira Gorizoker, Chief Commercial Officer, 00:01:09.502 -- 00:01:13.746 and Brian McMichael, Chief Financial Officer. 00:01:13.746 -- 00:01:17.609 Before we get started, I would like to remind you that today's call includes forward-looking 00:01:17.609 -- 00:01:23.155 statements regarding O'Hara's current expectations about future events. 00:01:23.155 -- 00:01:28.340 Actual resu...